Tuesday, July 11, 2017 2:08:45 PM
Maximum. In the ABSOLUTE best case scenario over 10. HOWEVER this would be contingent upon success in the clinic for SOLID TUMORS using the TriKE platform. Listen to the interview in the link below. Dr. Jeffery Miller, says the holy grail not just for TriKE but for any platform is solid tumors. Solid tumors make up a little over 75% of cancer. And so that means should their be success in the clinic for solid tumors. That the TriKE platform could be used for multiple different types of cancers and also leukemia. DON'T COUNT ON THIS HAPPENING THOUGH THIS IS VERY UNLIKELY TO HAPPEN
https://player.fm/series/chi-podcasts/pegs-boston-2017-generation-of-bikes-and-trikes
In terms of what I think the company will be acquired for? I think what will happen is the same thing is what happened with the new ceos previous company Chase. Oxis will be acquired before any of its drug have finished their trials for 500 million. However, assuming continued success in the trials, That amount could easily exceed 2 billion upon achieving certain milestones. (I.E moving into phase 3 potentially a royalty off sales once the drug is approved)
Finally, I'm going to assume a 1 for 100 reverse split. I believe once they publicly announce data from the OXS-1550, oxis share price will reach 10 cents a share. At this price they will do a reverse split up list to the nasdaq and do an ipo at $10 a share. Averse a reverse split there will be 4 million shares outstanding, and by the time the company is acquired there will be 60 million. (Additional selling of shares needed to fund the continuing trials and to compensate management.)
Here's the good news, thank God Cataldo is gone, the new management will not allow 750 million outstanding shares. I am sure Dr. Kathleen has no interest in running a penny stock. And once she officially becomes ceo, she will up list the company right away.
Sorry didn't answer this earlier thought all there was was (I agree with you!)
Recent GTBP News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/17/2024 08:26:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:25:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 05/24/2024 12:31:08 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/23/2024 10:04:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 10:02:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:00:40 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 05:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 08:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:00:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2023 10:25:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2023 10:23:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/06/2023 10:21:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 01:00:37 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 09:23:48 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 09/19/2023 03:56:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2023 08:55:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:29:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 11:26:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 01:00:11 PM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM